Table 2.
Treatment | LVEDP (mmHg) | LVESP (mmHg) | dP/dtmax (mmHg/s) | dP/dtmin (mmHg/s) |
---|---|---|---|---|
Control | 5.31 ± 0.43 | 93.74 ± 2.29 | 3134 ± 66 | −2610 ± 58 |
BPA | 5.96 ± 0.48 | 90.64 ± 0.91 | 3166 ± 40 | −2823 ± 82 |
BPS | 5.15 ± 0.41 | 90.72 ± 2.47 | 3142 ± 96 | −2440 ± 91 |
BPS + PHTTP | 5.28 ± 0.23 | 92.89 ± 1.87 | 3187 ± 63 | −2600 ± 89 |
Key: LVEDP, left ventricular end diastolic pressure; LVESP, left ventricular end systolic pressure; dP/dtmax, maximum rate of contraction; dP/dtmin, maximum rate of relaxation; BPA, bisphenol A (1 nM); BPS, bisphenol S (1 nM); PHTPP, estrogen receptor-β anatagonist (1 μM). N = 10 for all groups except N = 6 for BPS + PHTPP. Values presented are mean ± SEM.